Logo image of ERA.CA

ELCORA ADVANCED MATERIALS CO (ERA.CA) Stock Fundamental Analysis

TSX-V:ERA - TSX Venture Exchange - CA2844452029 - Common Stock - Currency: CAD

0.125  -0.01 (-3.85%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to ERA. ERA was compared to 802 industry peers in the Metals & Mining industry. ERA has a bad profitability rating. Also its financial health evaluation is rather negative. ERA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

ERA had negative earnings in the past year.
ERA had a positive operating cash flow in the past year.
ERA had negative earnings in each of the past 5 years.
In the past 5 years ERA always reported negative operating cash flow.
ERA.CA Yearly Net Income VS EBIT VS OCF VS FCFERA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

The Return On Assets of ERA (-62.59%) is worse than 67.40% of its industry peers.
Industry RankSector Rank
ROA -62.59%
ROE N/A
ROIC N/A
ROA(3y)-72.16%
ROA(5y)-144.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ERA.CA Yearly ROA, ROE, ROICERA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ERA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ERA.CA Yearly Profit, Operating, Gross MarginsERA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

0

2. Health

2.1 Basic Checks

ERA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ERA has been increased compared to 1 year ago.
ERA has less shares outstanding than it did 5 years ago.
ERA has a worse debt/assets ratio than last year.
ERA.CA Yearly Shares OutstandingERA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ERA.CA Yearly Total Debt VS Total AssetsERA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -21.86, we must say that ERA is in the distress zone and has some risk of bankruptcy.
ERA's Altman-Z score of -21.86 is on the low side compared to the rest of the industry. ERA is outperformed by 75.89% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -21.86
ROIC/WACCN/A
WACC8.52%
ERA.CA Yearly LT Debt VS Equity VS FCFERA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

2.3 Liquidity

ERA has a Current Ratio of 0.08. This is a bad value and indicates that ERA is not financially healthy enough and could expect problems in meeting its short term obligations.
ERA's Current ratio of 0.08 is on the low side compared to the rest of the industry. ERA is outperformed by 83.03% of its industry peers.
ERA has a Quick Ratio of 0.08. This is a bad value and indicates that ERA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ERA (0.05) is worse than 84.13% of its industry peers.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.05
ERA.CA Yearly Current Assets VS Current LiabilitesERA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

0

3. Growth

3.1 Past

ERA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.30%, which is quite impressive.
EPS 1Y (TTM)24.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ERA.CA Yearly Revenue VS EstimatesERA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 20K 40K 60K 80K 100K

0

4. Valuation

4.1 Price/Earnings Ratio

ERA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ERA.CA Price Earnings VS Forward Price EarningsERA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ERA.CA Per share dataERA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ERA!.
Industry RankSector Rank
Dividend Yield N/A

ELCORA ADVANCED MATERIALS CO

TSX-V:ERA (5/5/2025, 7:00:00 PM)

0.125

-0.01 (-3.85%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-26 2025-02-26
Earnings (Next)10-27 2025-10-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.57%
Ins Owner ChangeN/A
Market Cap2.13M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 17.6
P/FCF N/A
P/OCF 51.45
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0
OCFY1.94%
SpS0.01
BVpS-0.12
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -62.59%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-72.16%
ROA(5y)-144.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1200.98%
Cap/Sales 304.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.05
Altman-Z -21.86
F-Score3
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)687.73%
Cap/Depr(5y)413.83%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y75.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y108.1%
OCF growth 3YN/A
OCF growth 5YN/A